Danaher Corporation (DHR) To Go Ex-Dividend on December 26th

Danaher Corporation (NYSE:DHR) declared a quarterly dividend on Tuesday, December 9th. Investors of record on Friday, December 26th will be paid a dividend of 0.32 per share by the conglomerate on Friday, January 30th. This represents a c) annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, December 26th.

Danaher has raised its dividend by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 2 consecutive years. Danaher has a payout ratio of 14.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Danaher to earn $8.57 per share next year, which means the company should continue to be able to cover its $1.28 annual dividend with an expected future payout ratio of 14.9%.

Danaher Stock Up 1.3%

Shares of NYSE DHR opened at $230.96 on Wednesday. Danaher has a 1 year low of $171.00 and a 1 year high of $258.23. The firm has a 50-day simple moving average of $221.32 and a two-hundred day simple moving average of $207.61. The company has a market cap of $163.14 billion, a P/E ratio of 47.62, a PEG ratio of 4.42 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the business posted $1.71 earnings per share. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. Research analysts anticipate that Danaher will post 7.63 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.